Saved in:
Bibliographic Details
Main Authors: Hanimann, Jacob, Siegismund, Daniel, Wieser, Mario, Steigele, Stephan
Format: Preprint
Published: 2025
Subjects:
Online Access:https://arxiv.org/abs/2508.13701
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866913997738999808
author Hanimann, Jacob
Siegismund, Daniel
Wieser, Mario
Steigele, Stephan
author_facet Hanimann, Jacob
Siegismund, Daniel
Wieser, Mario
Steigele, Stephan
contents High-throughput screening using automated microscopes is a key driver in biopharma drug discovery, enabling the parallel evaluation of thousands of drug candidates for diseases such as cancer. Traditional image analysis and deep learning approaches have been employed to analyze these complex, large-scale datasets, with cell segmentation serving as a critical step for extracting relevant structures. However, both strategies typically require extensive manual parameter tuning or domain-specific model fine-tuning. We present a novel method that applies a segmentation foundation model in a zero-shot setting (i.e., without fine-tuning), guided by an in-context learning strategy. Our approach employs a three-step process for nuclei, cell, and subcellular segmentation, introducing a self-prompting mechanism that encodes morphological and topological priors using growing masks and strategically placed foreground/background points. We validate our method on both standard cell segmentation benchmarks and industry-relevant hit validation assays, demonstrating that it accurately segments biologically relevant structures without the need for dataset-specific tuning.
format Preprint
id arxiv_https___arxiv_org_abs_2508_13701
institution arXiv
publishDate 2025
record_format arxiv
spellingShingle subCellSAM: Zero-Shot (Sub-)Cellular Segmentation for Hit Validation in Drug Discovery
Hanimann, Jacob
Siegismund, Daniel
Wieser, Mario
Steigele, Stephan
Image and Video Processing
Computer Vision and Pattern Recognition
High-throughput screening using automated microscopes is a key driver in biopharma drug discovery, enabling the parallel evaluation of thousands of drug candidates for diseases such as cancer. Traditional image analysis and deep learning approaches have been employed to analyze these complex, large-scale datasets, with cell segmentation serving as a critical step for extracting relevant structures. However, both strategies typically require extensive manual parameter tuning or domain-specific model fine-tuning. We present a novel method that applies a segmentation foundation model in a zero-shot setting (i.e., without fine-tuning), guided by an in-context learning strategy. Our approach employs a three-step process for nuclei, cell, and subcellular segmentation, introducing a self-prompting mechanism that encodes morphological and topological priors using growing masks and strategically placed foreground/background points. We validate our method on both standard cell segmentation benchmarks and industry-relevant hit validation assays, demonstrating that it accurately segments biologically relevant structures without the need for dataset-specific tuning.
title subCellSAM: Zero-Shot (Sub-)Cellular Segmentation for Hit Validation in Drug Discovery
topic Image and Video Processing
Computer Vision and Pattern Recognition
url https://arxiv.org/abs/2508.13701